糖尿病瘦削与代谢 SCIE

期刊简介估计审稿时候： 普通,3-8周

Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.

《糖尿病、瘦削和代谢》首要登载临床和尝试药理学和医治学杂志，涵盖糖尿病、瘦削和代谢相干范畴。该杂志优先登载高品质的首创研讨，报告新疗法或现有疗法（包含饮食、活动和糊口体例（非药物）干涉干与）对人类或植物和细胞系统代谢和内排泄疾病任何方面的影响。“代谢”可以或许与脂质、骨骼和药物代谢或内排泄功效妨碍的更普遍方面有关。临床前药理学、药代能源学研讨、聚集阐发和触及药物宁静性和耐受性的研讨也很是合适在该杂志上颁发。首创研讨可以或许作为首要论文或研讨信函颁发。

《Diabetes Obesity & Metabolism》(糖尿病瘦削与代谢)编辑部通信体例为WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。